Safety, Effectiveness, and Subjective Experience with Topical Bimatoprost 0.03% for Eyelash Growth

• Published in: Dermatologic surgery 2010-05, Vol.36 (5), p.638-649
• Main Authors: YOELIN, STEVE, WALT, JOHN G., EARL, MELISSA
• Format: Article
• Language: English
• Subjects: Administration, Topical; Adult; Aged; Amides - administration & dosage; Antihypertensive Agents - administration & dosage; Bimatoprost; Biological and medical sciences; Cloprostenol - administration & dosage; Cloprostenol - analogs & derivatives; Dermatology; Eyelashes - drug effects; Eyelashes - growth & development; Female; Follow-Up Studies; Humans; Intraocular Pressure - drug effects; Male; Medical sciences; Middle Aged; Prospective Studies; Skin plastic surgery; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Surveys and Questionnaires; Treatment Outcome
• ISSN: 1076-0512; 1524-4725
• DOI: 10.1111/j.1524-4725.2010.01519.x

BACKGROUND Ocularly applied bimatoprost 0.03% is associated with increased eyelash growth. OBJECTIVE To assess the safety, efficacy, and subjective experience of using dermal application of bimatoprost 0.03% for the growth of natural eyelashes. METHODS Prospective, open‐label study of subjects who desired longer, thicker (fuller), and darker natural eyelashes. Bimatoprost was applied to the upper lid margin once daily for 12 weeks. Adverse events and intraocular pressure were assessed, and subjects completed health outcomes questionnaires. Eyelash growth and darkening were scored using photographs taken at weeks 1 and 12. RESULTS All subjects were female (N=28). No serious or unexpected adverse events were reported. The mean change from baseline intraocular pressure was less than 1 mmHg at each time point, but was statistically significant at weeks 1 and 4 (p≤.047). At week 12, all subjects had noticed significant growth or darkening. Post hoc analysis of photographs corroborated these reports (p